This webinar will provide valuable guidance to regulated companies in development and implementation of formal, defined, documented methods for analysis of product changes and when to file a new 510(k).
Consideration of the U.S . FDA’s current K-97-1 Memo / guidance document on “510(k) Device Modifications”
Control of medical device changes and a current 510(k) are big issues in recent FDA studies. Companies are held fully responsible for deciding when a new 510(k) filing is warranted. Often this is a difficult decision process. Effective change control and the power of current risk management tools must be a major part of such an analysis. The U.S. FDA has its current K-97-1 Memorandum (they recently pulled their proposed new draft Guidance Document, “510(k) Device Modifications: Deciding When to Submit a 510(k) for a Change to an Existing Device”). K97-1 provides a tool to assist in device and new 510(k) / change analysis. The addition of such simple tools will assist companies in implementing formal, documented, repeatable methods with defensible rationale for their decisions on when changes trigger the need for a new 510(k) submission.
The K97-1 analysis is the preferable tool to work with a company’s change control system to document the need to file, or the rationale for not submitting a 510(k). It is recommended as the preferred method for documentation of each change in a device during its lifecycle. Provides for a Step-by-step analysis: Manufacturing, Labeling, Tech / Performance, and/or Materials Changes. Consideration of which of the three major 510(k) formats should be used: Traditional, Special or Abbreviated.
Areas to be Covered:
This webinar will provide valuable assistance to all regulated companies performing and documenting meaningful, results driven 510(k) / change analysis activities, based on the FDA’s current Guidance on 510(k) Device Modifications. This session will cover:
Deciding When to Submit a 510(k) for a Change to an Existing Device, K97-1
How to provide tools to document such decisions
It will discuss how companies can best document their decisions — whether or not a new 510(k) filing is warranted
How to structure a decision matrix to document change decisions
How to evaluate changes that could trigger the “Tipping Point”
Who makes the decisions and how to defend them
How to implement formal methods with documented, and defensible rationale
Preparing for further 510(k) changes in the future
Who will Benefit:
This webinar is a must for companies in the Medical Device and combination products fields. The employees who will benefit include:
Research & Development
Lean & Six Sigma staff
New Product Development
Mid-level and Senior Management